In this issue:
Kidney function and outcomes in hospitalised HF
Effect of EF on clinical outcomes in omecamtiv mecarbil-treated HFREF
Evidence-based assessment of genes in DCM
ICD eligibility after initiation of sacubitril/valsartan for chronic HF
Neprilysin inhibition and LV remodelling in post-MI asymptomatic LV systolic dysfunction
Physical rehabilitation for older hospitalised HF patients
SGLT-2 inhibitors decrease CV death and HF hospitalisations in HF patients
HF outcomes in Aboriginal and Torres Strait Islander peoples
Dapagliflozin and recurrent HF hospitalisations in HFREF
Association of CHIP with incident HF
Please login below to download this issue (PDF)